ESC Premium Access

Are there effects of PCSK9 inhibitors beyond cholesterol lowering?

Congress Presentation

About the speaker

Professor Bertrand Cariou

Thorax institute, INSERM UMR 1087, CHU Nantes, Nantes (France)
0 follower

3 more presentations in this session

A global view: the rationale for aggresive LDL lowering

Speaker: Professor S. Nissen (Cleveland, US)


Cholesterol metabolism and the role of PCSK9

Speaker: Professor S. Nicholls (Melbourne, AU)


Show me the data: clinical efficacy, safety and indications of PCSK9 inhibition

Speaker: Professor J. Jukema (Leiden, NL)


Access the full session

PCSK9 inhibition - cholesterol reduction and beyond

Speakers: Professor B. Cariou, Professor S. Nissen, Professor S. Nicholls, Professor J. Jukema

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb